Your browser doesn't support javascript.
loading
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
Tessoulin, B; Thomare, P; Delande, E; Moynard, J; Gastinne, T; Moreau, A; Bossard, C; Mahé, B; Blin, N; Dubruille, V; Touzeau, C; Boudreault, J S; Perrin, F; Lok, A; Guillaume, T; Garnier, A; Peterlin, P; Gallas, P; Chevallier, P; Moreau, P; Le Gouill, Steven.
Afiliação
  • Tessoulin B; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Thomare P; INSERM, UMR892, Equipe 10, Nantes, France.
  • Delande E; Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, University Hospital of Nantes, Nantes, France.
  • Moynard J; Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, University Hospital of Nantes, Nantes, France.
  • Gastinne T; Pharmacy Clinical Oncology Unit (UPCO), Department of Pharmacy, University Hospital of Nantes, Nantes, France.
  • Moreau A; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Bossard C; Department of Pathology, University Hospital of Nantes, Nantes, France.
  • Mahé B; Department of Pathology, University Hospital of Nantes, Nantes, France.
  • Blin N; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Dubruille V; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Touzeau C; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Boudreault JS; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Perrin F; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Lok A; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Guillaume T; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Garnier A; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Peterlin P; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Gallas P; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Chevallier P; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Moreau P; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
  • Le Gouill S; Service d'hématologie clinique, CHU de Nantes, place Alexis Ricordeau, 44000, Nantes, France.
Ann Hematol ; 96(6): 943-950, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28374163
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article